UNC-Chapel Hill, Hamner Institutes Announce Partnership to Accelerate Basic, Translational Research
Established with Carolina's schools of medicine, pharmacy and publichealth, and its Kenan-Flagler Business School, this unique partnershipcapitalizes on the scientific strengths of a leading university and anindependent research institute, both of which are committed to acceleratingadvances in human therapeutics and public health locally and internationally.Key initial areas of anticipated collaboration include pursuit of newtherapies for cancer and respiratory diseases by advancing experimental andcomputational sciences in drug safety assessment, drug disposition,pharmacogenomics, genomic medicine, nanomedicine, drug delivery and publichealth.
The scientific and business-development teams at The Hamner Instituteswill work with Carolina faculty, including those from the Center forIntegrative Chemical Biology and Drug Discovery in the Schools of Pharmacy,Medicine and College of Arts and Sciences, UNC Kenan-Flagler Business Schooland the University's Office of Technology Development to identify, assess andenhance development of new research leads. Together, they willcollaboratively pursue a wide array of research grant opportunities fromgovernment, industry and non-profit organizations to accelerate development ofpromising research and technologies that can be licensed out and/or spun outinto the University's new innovation center.
This new partnership between The Hamner Institutes and the University willalso draw upon extensive resources available at the state's other academicinstitutions and the North Carolina Biotechnology Center, which supportsstatewide faculty recruitment, scientific education, economic development andtechnology development.
"At Carolina, we are committed to making sure that the discoveries ofbasic science benefit people," said UNC-Chapel Hill Chancellor James Moeser."This partnership with the Hamner Institutes will help us accelerate thedevelopment of valuable new drugs, treatments and technologies that improvehealth and also yield new economic opportunities for North Carolinians."
"We are extremely pleased and honored to be joining with one of theworld's leading research universities to create a unique integrative model fortranslating basic science research into new medicines," said Dr. WilliamGreenlee, President and CEO of The Hamner Institutes for Health Sciences."This partnership also will foster new alliances between academe, industry andgovernment regulatory agencies to advance public health research, educationand scientifically informed policies."
About The Hamner Institutes for Health Sciences:
Strategically located on a 56-acre campus in North Carolina's ResearchTriangle Park, The Hamner Institutes for Health Sciences is across-disciplinary nonprofit organization that acts as a catalyst tofacilitate scientific collaborations -- both locally and internationally --between academia, the private sector and government. For more than 30 years,Hamner scientists have been recognized for their public-policy leadership andresearch advances in fields such as risk assessment, dose-response modelingand inhalation drug delivery. For more information, visit www.thehamner.orgor call (919) 558-1200.Contact: Patty Briguglio 919-233-6600
SOURCE The Hamner Institutes for Health Sciences
You May Also Like